MONTREAL Many in the international science community reacted with disappointment and not a little frustration on Wednesday, after finally seeing statistical data from a study on the effectiveness of medication colchicine. “We can confirm that the primary outcome was not statistically significant,” said Dr. Emily McDonald a scientist at the MUHC’s Research Institute. The anti-inflammatory drug, now used to treat gout was touted by the Montreal Heart Institute just days ago in a press release, as an effective oral medication for non-hospitalized COVID-19 patients. In a Friday press release, the MHI researchers claimed the drug reduced the risk of death or hospitalization for COVID-19 by 21 per cent.
So much more of the story we re missing : Quebec doctors urge caution on new study to treat the coronavirus with colchicine
montreal.ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montreal.ctvnews.ca Daily Mail and Mail on Sunday newspapers.
Pandemic fuels interest in cosmetic procedures, but critics question the timing
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.